The Complement-Based Drug Development Summit, now in its 9th year, brings together industry experts to address challenges in complement-mediated th...
Eli Lilly is preparing for the regulatory approval and global launch of its new weight loss pill after successful late-stage clinical trials. The p...
Multiply Labs, a robotics company, has developed a robotic biomanufacturing cluster that reduces costs by 74% for cell therapies. This system uses ...
The Antifibrotic Drug Development Summit is set to take place this November, showcasing significant advancements in the field of antifibrosis. The ...
Recent research has demonstrated that the HDAC inhibitor romidepsin can make liver cancer cells more susceptible to RTK targeting, enhancing their ...
Devonian Health Group Inc., a clinical stage pharmaceutical company, has provided a corporate update regarding its ongoing projects and financial a...
Devonian Health Group Inc., a clinical-stage pharmaceutical company, has announced significant advancements in the development of Thykamine, a drug...
Argenx, a Netherlands-based pharmaceutical company, has released positive results from its ADAPT SERON trial for Vyvgart (efgartigimod), a drug des...
Sawgrass Nutra Labs has announced the completion of its expansion into a new 40,000 square foot state-of-the-art manufacturing facility. This expan...
A recent study has highlighted the role of perirenal fat in contributing to obesity-related health complications, alongside hepatic fat. The resear...